findmyKOL
Clinical trialNCT00427414TerminatedPhase 1Interventional

Liposomal Daunorubicin in Treating Patients With HIV-Related Kaposi's Sarcoma

SponsorAIDS Malignancy ConsortiumEnrollment14Sarcoma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Brazil
  • Centro de Referencia E Tratamento Dst/aids

    São Paulo, São Paulo, Brazil

  • Instituto de Infectologia Emilio Ribas Hospital

    Cerqueira Cesar - Sao Paulo/SP, Brazil

United States
  • University of Miami Sylvester Comprehensive Cancer Center - Miami

    Miami, Florida, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Sept 2008
Primary completion
30 Nov 2010
Completion
30 Nov 2011
Last update posted
29 Apr 2015
Registered enrollment
14
Registry id
NCT00427414
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.